Tag: health-insurance
Oscar Health Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
Oscar Health (OSCR) is rated Hold as rapid revenue growth and strong free cash flow are offset by uneven margins and meaningful debt. The stock looks reasonably priced, but the earnings base still needs more proof before the upside case is fully convincing.
Cigna Group Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margin
The Cigna Group (CI) is rated Hold as its durable cash generation offsets a post-divestiture earnings base that still needs to prove itself. The 9.0% FCF yield and 1.72x net debt to EBITDA support the stock, but margin improvement remains the key test.